Skip to main content
Sensorion logo

Sensorion — Investor Relations & Filings

Ticker · ALSEN ISIN · FR0012596468 LEI · 969500P0W8XJ9CGZDP97 PA Professional, scientific and technical activities
Open in API
Filings indexed 566 across all filing types
Latest filing 2026-05-18 Board/Management Inform…
Country FR France
Listing PA ALSEN

About Sensorion

https://www.sensorion.com/en/

Sensorion is a clinical-stage biotechnology company specializing in the development of novel therapies for inner ear disorders. The company's mission is to address the significant unmet medical need of hearing loss by creating innovative therapeutic solutions. Its strategy is built on three pillars: restoring hearing through gene therapies for genetic diseases, treating existing hearing disorders with small molecule therapeutics, and preventing non-genetic hearing loss, such as drug-induced ototoxicity. Sensorion utilizes a unique R&D technology platform to advance its understanding of the pathophysiology of inner ear diseases and develop its pipeline of clinical candidates.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Board/Management Information Classification · 92% confidence The document is a corporate press release announcing the appointment of a new Chief Executive Officer and noting changes in the Board of Directors and senior management roles. There is no financial data or reporting period, and it clearly falls under announcements of board or management changes.
2026-05-18 English
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 92% confidence The document is a corporate press release in French announcing the appointment of a new Chief Executive Officer and changes in senior management positions. It does not contain financial statements, voting results, or regulatory filings, but specifically relates to board and executive management changes. This matches the Board/Management Information category.
2026-05-18 French
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a press release announcing the voting outcomes of resolutions put to a Combined General Meeting (CGM), including adoption rates and percentage of capital represented. It is not the meeting materials themselves nor a full report, but specifically the declaration of shareholder voting results. This fits the category for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-13 English
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release announcing the vote results from Sensorion’s combined Annual General Meeting held on May 11, 2026. It does not contain financial statements or management changes but specifically discloses shareholder voting outcomes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-13 French
Inside Information / Other news releases
Investor Presentation Classification · 85% confidence The document is a press release announcing Sensorion's participation in the American Society of Gene & Cell Therapy Annual Meeting, detailing presentations by company representatives. It contains no financial data, no regulatory filings, no voting results, no management changes, no earnings or annual report information. It is a corporate announcement about participation in a scientific conference, which aligns with an Investor Presentation (IP) type document as it focuses on company activities, strategy, and scientific presentations relevant to investors and stakeholders. The document length is about 4,835 characters, which is consistent with a press release rather than a full report. Therefore, the best classification is Investor Presentation (IP).
2026-05-05 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release announcing Sensorion's participation in an upcoming scientific conference (ASGCT) and detailing presentations by company representatives. It includes company background information and contact details. There is no financial data, no report attached or referenced as being published, and no regulatory filing or certification. The content is promotional and informational about an event, not a financial report or regulatory announcement. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit any other specific category.
2026-05-05 French

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.